3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
16
Uterine Cervical Neoplasms
5
Stomach Neoplasms
5
Lung Neoplasms
5
Carcinoma, Transitional Cell
5
Carcinoma, Hepatocellular
5
Squamous Cell Carcinoma of Head and Neck
4
Sarcoma
4
Prostatic Neoplasms
4
Ovarian Neoplasms
4
Oropharyngeal Neoplasms
4
Esophageal Neoplasms
4
Cholangiocarcinoma
4
Urinary Bladder Neoplasms
3
Thyroid Neoplasms
3
Neuroendocrine Tumors
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Lymphoma, Large B-Cell, Diffuse
3
Anus Neoplasms
3
Testicular Neoplasms
2
Solid Tumor
2
Pheochromocytoma
2
Paraganglioma
2
Pancreatic Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Melanoma
2
Leukemia, Myeloid, Acute
2
Laryngeal Neoplasms
2
Interventions
Magnetic Resonance Spectroscopy
5
trametinib
4
Vemurafenib
4
selpercatinib
3
dabrafenib
3
Specimen Handling
3
entrectinib
2
cobimetinib
2
cabozantinib
2
X-Rays
2
Iodine-131
2
Interviews as Topic
2
tremelimumab
1
tovorafenib
1
spartalizumab
1
pembrolizumab
1
omipalisib
1
lenvatinib
1
gallium Ga 68 dotatate
1
durvalumab
1
copanlisib
1
Whole Body Imaging
1
Transurethral Resection of Prostate
1
Thyrotropin Alfa
1
Surveys and Questionnaires
1
Sodium Iodide
1
Robotic Surgical Procedures
1
Postoperative Period
1
Phantoms, Imaging
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Cancer, Papillary
×
Fluorodeoxyglucose F18
×
1 year
×
Clear all
No trials found.